Literature DB >> 19237627

Early stopping for benefit in National Cancer Institute-sponsored randomized Phase III trials: the system is working.

Daniel Sargent.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19237627     DOI： 10.1200/JCO.2008.20.8611

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

1.  How to interpret a randomized controlled study stopped early.

Authors:  G Leandro
Journal:  Intensive Care Med       Date:  2013-09       Impact factor: 17.440

2.  Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.

Authors:  Robert J Glynn; Wolfgang Koenig; Børge G Nordestgaard; James Shepherd; Paul M Ridker
Journal:  Ann Intern Med       Date:  2010-04-20       Impact factor: 25.391
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.